Joseph S. Podolski

Part of Skillsoft Corp., Forefront Group, Inc. develops Internet and software applications. The company is based in Houston, TX. The CEO of the company is Michael S. Hedge. Forefront Group was acquired by SmartForce Plc on June 01, 1998 for $104.03 million.

Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA.

Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA.

Axellis, Inc. sells and distributes medical devices. Its products are used for oncology and cardiology. The company was founded in August 2007 and is headquartered in London, UK

Jackson Walker LLP provides legal services. Its practice areas include energy law, government affairs, insurance, health care, labor and employment and intellectual property. The company was founded in 1887 and is headquartered in Dallas, TX.

Winstead PC provides legal services. Its services include appellate, banking and credit transactions, biotechnology, intellectual property, commercial litigation, construction, insurance, telecommunications, and transportation. The firm has offices in Austin, Dallas, Fort Worth, Houston, and San Antonio. The company was founded in 1973 and is headquartered in Dallas, TX.

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA.

U.S. Anti-Doping Agency is a non-profit organisation. It is the national anti-doping organization in the United States for Olympic, Paralympic, Pan American, and Parapan American sport. The company is charged with managing the anti-doping program, including in-competition and out-of competition testing, results management processes, drug reference resources, and athlete education for all United States Olympic Committee recognized sport national governing bodies, their athletes, and events. It contributes to the advancement of clean sport through scientific research and education & outreach initiatives focused on awareness and prevention. The company was founded on October 1, 2000 and is headquartered in Colorado Springs, CO.

Morvus Technology Ltd. discovers, develops and commercializes of novel drugs and technologies in the oncology field. Its products include clinical candidates, research portfolio and non-core programmes. The company was founded by Philip John Burke and Roger Geoffrey Melton in April 2004 and is headquartered in Carmarthen, the United Kingdom.

CONNECT creates and scales companies in the technology and life sciences sectors. It creates an environment in which entrepreneurs and C-suite executives have access to the people, capital, and technology resources. The organization was founded in 1985 and is headquartered in San Diego, CA.

New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT.

Part of Aytu Biopharma, Inc., GlycoMar Ltd. is a European center for marine biotechnology and glycobiology. The company is based in Oban, UK. The British company pursues untapped biological and chemical diversity to identify new drug candidates from marine organisms. GlycoMar was acquired by Rosewind Corp. on January 11, 2013 for $13.01 million.

Part of Regent Pacific Group Ltd., Plethora Solutions Ltd. is a specialty pharmaceutical company based in Chalgrove, UK. The British company's principal product is a treatment remedy for male premature ejaculation, which obtained marketing authorization from the European Commission in 2013. With more than 25 million men suffering from premature ejaculation, the company aims to meet the poorly met medical needs of this expanding market. The company provides information on their website for business development and investor relations purposes only, and patients who suffer from premature ejaculation should contact their physician in the first instance. Founded in 2003, the company is dedicated to developing and marketing products for the treatment and management of urological disorders.

EF Resources, Inc. provides technology services. The company was founded by Michael Racusin, Phillip Racusin and Casey Minshew in 2013 and is Headquartered in Houston, TX.

Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada.

NeoPure Technologies LLC delivers customized solutions for sterilization, drinking water purification, waste water treatment, odor resolving of waste water methane removal, phosphorus removal, and water renewal. Its products include pathocell anode, brinecell anode, electro-oxidation generator, chlorozone generator, chlorine generator, bleach generator, and sodium hypochlorite generators. The firm serves industrial cooling, aquatics, environmental, food and beverage, mining, oil and gas, power and veterinary industries. The company was founded in 2012 and is headquartered in Stafford, TX.

Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018.